Frank Wiegand

1.9k total citations
35 papers, 1.4k citations indexed

About

Frank Wiegand is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Frank Wiegand has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Frank Wiegand's work include Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Frank Wiegand is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (7 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Frank Wiegand collaborates with scholars based in United States, Germany and Belgium. Frank Wiegand's co-authors include Ulrich Dirnagl, Karsten Ruscher, Andreas Meisel, Ella Daly, Jaskaran Singh, Wayne C. Drevets, Pascal Sienaert, Maggie Fedgchin, Luc Van Nueten and Joseph Hulihan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Frank Wiegand

34 papers receiving 1.4k citations

Peers

Frank Wiegand
Yu‐Li Liu Taiwan
Anteneh M. Feyissa United States
Claire Leroy France
In‐Ho Paik South Korea
János Kálmán Hungary
W. Joseph Herring United States
Jennifer R. Cracchiolo United States
Ansel T. Hillmer United States
Takashi Futamura Japan
Dekun Song United States
Yu‐Li Liu Taiwan
Frank Wiegand
Citations per year, relative to Frank Wiegand Frank Wiegand (= 1×) peers Yu‐Li Liu

Countries citing papers authored by Frank Wiegand

Since Specialization
Citations

This map shows the geographic impact of Frank Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Wiegand more than expected).

Fields of papers citing papers by Frank Wiegand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Wiegand. The network helps show where Frank Wiegand may publish in the future.

Co-authorship network of co-authors of Frank Wiegand

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Wiegand. A scholar is included among the top collaborators of Frank Wiegand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Wiegand. Frank Wiegand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Turkoz, Ibrahim, et al.. (2021). Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials. Neuropsychiatric Disease and Treatment. Volume 17. 3459–3470. 7 indexed citations
3.
Kern, David M., M. Soledad Cepeda, & Frank Wiegand. (2021). Treatment patterns of patients diagnosed with major depressive disorder and suicidal ideation or attempt: a U.S. population-based study utilizing real-world data. BMC Psychiatry. 21(1). 608–608. 9 indexed citations
4.
Wajs, Ewa, Leah Aluisio, Ibrahim Turkoz, et al.. (2020). Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data. The International Journal of Neuropsychopharmacology. 23(7). 426–433. 15 indexed citations
5.
Sweiti, Hussein, et al.. (2019). Physicians in the pharmaceutical industry: their roles, motivations, and perspectives. Drug Discovery Today. 24(9). 1865–1870. 8 indexed citations
6.
Wiegand, Frank, et al.. (2018). Recherchieren, Arbeiten und Publizieren im Deutschen Textarchiv: ein Praxisbericht. Zeitschrift für Germanistische Linguistik. 46(1). 147–161. 2 indexed citations
7.
Mahlich, Jörg, et al.. (2017). Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study. Drugs - Real World Outcomes. 5(1). 35–43. 40 indexed citations
8.
Singh, Jaskaran, Maggie Fedgchin, Ella Daly, et al.. (2015). Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biological Psychiatry. 80(6). 424–431. 320 indexed citations
9.
Kimko, Holly, Ekaterina Gibiansky, Leonid Gibiansky, et al.. (2012). Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis. Journal of Pharmacokinetics and Pharmacodynamics. 39(2). 161–176. 32 indexed citations
10.
Cepeda, M. Soledad, et al.. (2012). Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis. Pain Medicine. 13(4). 575–595. 50 indexed citations
11.
Meador, Kimford J., H. Robert Brashear, Frank Wiegand, Peter Zannikos, & Gerald Novak. (2011). Cognitive effects of carisbamate in randomized, placebo-controlled, healthy-volunteer, multidose studies. Epilepsy & Behavior. 22(2). 324–330. 1 indexed citations
12.
Loring, David W., et al.. (2010). Topiramate dose effects on cognition. Neurology. 76(2). 131–137. 80 indexed citations
13.
Piña-Garza, J. Eric, et al.. (2010). A pilot study of topiramate in childhood absence epilepsy. Acta Neurologica Scandinavica. 123(1). 54–59. 15 indexed citations
14.
Elble, Rodger J., et al.. (2010). Carisbamate in essential tremor: Brief report of a proof of concept study. Movement Disorders. 25(5). 634–638. 15 indexed citations
15.
16.
Harms, Hendrik, Frank Wiegand, Dirk Megow, et al.. (2000). Acute treatment of hypertension increases infarct sizes in spontaneously hypertensive rats. Neuroreport. 11(2). 355–359. 13 indexed citations
17.
Prass, Konstantin, Frank Wiegand, Pascale Schumann, et al.. (2000). Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent. Brain Research. 871(1). 146–150. 77 indexed citations
18.
Wiegand, Frank, Susanne Koeppen, Peter Häussermann, & A Delcker. (1999). Neurozystizerkose. Der Nervenarzt. 70(4). 298–305. 9 indexed citations
19.
Turski, Lechosław, Andreas Huth, Malcolm J. Sheardown, et al.. (1998). ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proceedings of the National Academy of Sciences. 95(18). 10960–10965. 128 indexed citations
20.
Weih, Markus, Н. К. Исаев, Andreas Meisel, et al.. (1997). Induction of tolerance in rat cortical neurons: hypoxic preconditioning. FEBS Letters. 414(1). 117–121. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu‐Li Liu Breakdown of academic impact, for papers by Anteneh M. Feyissa Breakdown of academic impact, for papers by Claire Leroy Breakdown of academic impact, for papers by In‐Ho Paik Breakdown of academic impact, for papers by János Kálmán Breakdown of academic impact, for papers by W. Joseph Herring Breakdown of academic impact, for papers by Jennifer R. Cracchiolo Breakdown of academic impact, for papers by Ansel T. Hillmer Breakdown of academic impact, for papers by Takashi Futamura Breakdown of academic impact, for papers by Dekun Song
Rankless by CCL
2026